North America to Dominate Restriction Endonuclease Market until 2025
Increasing funding in
genomics and life science along with surging geriatric populations to drive the
growth of global restriction endonuclease market
According
to TechSci Research report, “Global
Restriction
Endonuclease Market By Type (I, II, III, IV), By Application (Genetic
Engineering, DNA Mapping, Gene Sequencing and Others), By End Type (Sticky End,
Blunt End), By Source (Bacteria, Archaea), By Cleavage Specificity
(Isoschizomers, Neoschizomers), By End-User (Pharmaceutical and Biotechnology
Companies, A6cademic Research Institutes and Others), By Region, Competition, Forecast & Opportunities,
2025”, global restriction endonuclease market is expected
to grow an impressive CAGR over the forecast period. Rapid rising funding in
genomics and life science is
one of the major factor accounting for the growth of global
restriction endonuclease market. Moreover, number of geriatric populations is
increasing at an alarming rate which is further expected to bode well for the growth
of global restriction endonuclease through the forecast years. In addition to
this, new advanced techniques are evolved such as DNA sequencing and gene
expression, which in turn is positively influencing the growth of global restriction
endonuclease market. Also, growing use of these restriction endonucleases in
various applications such as in vivo gene editing, building DNA libraries,
among others is making headway for the growth of global restriction
endonuclease market over the coming years. However, there are some factors such
as high cost required for the production of restriction endonuclease and level
of unreliability of these enzymes that can act as major impediments to the
growth of global restriction endonuclease market through 2025.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on"Global Restriction
Endonuclease Market"
https://www.techsciresearch.com/report/restriction-endonuclease-market/4638.html
Global
restriction endonuclease market can be segmented based on type, application,
end type, source, cleavage, end-user,
company and region. Considering the end-user, the market is
fragmented into pharmaceutical and biotechnology companies, academic research
institutes and others. The pharmaceutical and biotechnology companies segment dominated
the global restriction endonuclease market in terms of largest market size
until 2019 and is further anticipated to maintain its dominance during the
forecast period as well which can be accredited to growing utilization of restriction
endonuclease to map DNA and to cut and splice it for use in genetic engineering.
Additionally, it helps in diagnosis of hereditary diseases and detects various
infectious diseases which is further aiding the growth of the segment. In terms
of application, the market is fragmented into genetic engineering, DNA mapping,
gene sequencing and others. Out of which, the genetic engineering application segment
is projected to grow at a high pace during the forecast period which can be
accredited to its use to produce recombinant DNAs.
New England Biolabs, Thermo Fisher
Scientific, Takara Bio, Sigma-Aldrich, Illumina, Agilent Technologies, Promega,
Jena Biosciences, Genetix Biotech Asia Pvt. Ltd., Roche, Merck, Pfizer, Amgen,
Vertex Pharmaceuticals, BioMarin Pharmaceutical, PerkinElmer, Abcam, Abbexa,
Sisco Research Laboratories Pvt Ltd, Nippon Gene are among others
are the leading players operating in global restriction endonuclease market. The leading players are adopting several growth strategies
to enhance the market scenario of restriction endonuclease. Other competitive
strategies include mergers & acquisitions to diverse their product
portfolio in order to strengthen their market position.
Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4638
customers can also request for 10% free customization on
this report.
“North America is
forecast to dominate the global restriction endonuclease market during the next
five years on account of presence of strong research and development in
biotechnology in the region. Moreover, rising contract research outsourcing
coupled with increasing research in the fields of life science is also contributing
to the growing trend. Furthermore, Asia-Pacific region is anticipated to
register high growth through 2025 due to continuously developing healthcare
infrastructure and rising patient awareness. Moreover, beneficial government
initiatives are further boosting the market growth in the region.”, said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“Global Restriction Endonuclease Market By Type (I,
II, III, IV), By Application (Genetic Engineering, DNA Mapping, Gene Sequencing
and Others), By End Type (Sticky End, Blunt End), By Source (Bacteria,
Archaea), By Cleavage Specificity (Isoschizomers, Neoschizomers), By End-User
(Pharmaceutical and Biotechnology Companies, Academic Research Institutes and
Others), By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global
restriction endonuclease market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges and opportunities in global restriction
endonuclease market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]